(Q41689738)

7 October 2017

1 reference

title

Synthetic oligonucleotides: useful molecules? A review (English)

1 reference

7 October 2017

Calogero A

1

1 reference

7 October 2017

Hospers GA

series ordinal

2

1 reference

7 October 2017

Mulder NH

series ordinal

3

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

International Journal of Clinical Pharmacy

7 October 2017

1 reference

7 October 2017

19

1 reference

7 October 2017

264-268

1 reference

7 October 2017

6

1 reference

Gene replacement strategies for cancer

7 October 2017

1 reference

12 December 2020

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

1 reference

12 December 2020

Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor

1 reference

12 December 2020

Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.

1 reference

12 December 2020

Progress in antisense therapeutics

1 reference

12 December 2020

Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms

1 reference

12 December 2020

Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices

1 reference

12 December 2020

Oligonucleotide sequences required for natural killer cell activation

1 reference

12 December 2020

Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus

1 reference

12 December 2020

Immunomodulation by cytokine antisense oligonucleotides.

1 reference

12 December 2020

Oligonucleotide-mediated modulation of mammalian gene expression.

1 reference

12 December 2020

Antisense oligonucleotides: an experimental strategy to advance a causal analysis of development.

1 reference

12 December 2020

Application of ribozymes to cancer gene therapy.

1 reference

12 December 2020

Antitumor effects of antisense phosphorothioate c-myc oligodeoxynucleotides: a question of mechanism

1 reference

12 December 2020

Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.

1 reference

12 December 2020

In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes

1 reference

12 December 2020

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

12 December 2020

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008699515124

1 reference

7 October 2017

1 reference